ETILX - Eventide Gilead I

Nasdaq - Nasdaq Delayed Price. Currency in USD
+0.28 (+0.84%)
At close: 5:12PM EST
Stock chart is not supported by your current browser
Previous Close33.18
YTD Return26.59%
Expense Ratio (net)1.20%
CategoryMid-Cap Growth
Morningstar Rating★★★★
Morningstar Risk Rating★★★★★
Last Cap Gain0.00
Net Assets1.49B
Beta (3y)1.31
Holdings Turnover26.00%
Last Dividend0.00
Inception DateFeb 2, 2010
Average for CategoryN/A
  • PR Newswire4 months ago

    Eventide Gilead Fund Named a WSJ Category King

    BOSTON, July 31, 2017 /PRNewswire/ -- The Eventide Gilead Fund (NASDAQ: ETGLX, NASDAQ: ETAGX, NASDAQ: ETCGX, NASDAQ: ETILX) received a Wall Street Journal "Category King" on June 30, 2017. The award recognizes the top 10 funds in each equity category for one-year total return performance.

  • Marketwired10 months ago

    Eventide Funds Announces 2016 Results

    Eventide Funds announced 2016 results for the Eventide Gilead Fund , Eventide Healthcare & Life Sciences Fund , and...

  • We're sorry this is all we were able to find about this topic.